Notice of Change in Participation of NIH Institutes and Centers in PA-10-138 Development of Animal Models and Related Biological Materials for Research (R21)


Notice Number: NOT-OD-12-054

 
Key Dates

Release Date: February 29, 2012

Issued by

National Institutes of Health (NIH)

Purpose

The purpose of this Notice is to inform potential applicants of changes in the participation of NIH Institutes, Centers, and Offices (ICOs) in PA-10-138 Development of Animal Models and Related Biological Materials for Research (R21) .

Background

On December 23, 2011, the National Center for Research Resources (NCRR) was dissolved and the National Center for Advancing Translational Sciences (NCATS) and the Office of Research Infrastructure Programs (ORIP) were established. As indicated in NOT-OD-12-026, all NCRR programs were transferred to other NIH ICOs. Additionally, the responsibility for all Funding Opportunity Announcements (FOAs) in which NCRR participated is being transferred to other ICOs. Please visit the NCRR website for more information regarding the transfer of NCRR programs to other NIH ICOs.

Implementation

The following sections of PA-10-138 have been revised to reflect the changes that resulted from this reorganization of NIH ICOs.

The Components of Participating Organizations section has been revised to remove NCRR and include the Office of Research Infrastructure Programs (ORIP):

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

The Catalog of Federal Domestic Assistance (CFDA) Number section has been revised to reflect the updated list of participating ICOs.

The NCRR CFDA number has been removed: 93.389

The following CFDA number for ORIP have been added: 93.351

All Agency Contacts listed in this FOA are now located in ORIP and may still be contacted with inquiries about this FOA.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to the appropriate Scientific/Research Contact listed in the FOA.